Find a Clinical Trial

Filter

Showing 1 - 8 out of 8

Allogenic Hepatocyte Transplantation into Periduodenal Lymph Nodes

A Phase 2a, Open Label, Dose Escalation Study for Safety, Tolerability, and Efficacy of Hepatocyte Transplantation Into Periduodenal Lymph Nodes Among Subjects With End-Stage Liver Disease

Liver diseases

All genders

18-70

Recruiting now

Department of Medicine, Division of Gastroenterology + Hepatology

Tufts Medical Center

Learn more

Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)

A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer (VOLGA)

Bladder cancer

All genders

18+

Recruiting now

Department of Medicine, Cancer Center

Tufts Medical Center

Learn more

Clinical Outcomes Of Primary Sclerosing Cholangitis In North America

Sclerosing cholangitis

All genders

No minimum age

Recruiting now

Department of Medicine, Division of Gastroenterology + Hepatology

Tufts Medical Center

Learn more

Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer

Bladder cancer

All genders

18-90

Recruiting now

Department of Urology

Tufts Medical Center

Learn more

HIP ATTACK-2

HIP Fracture Accelerated surgical TreaTment And Care tracK 2 (HIP ATTACK-2) Trial

Hip injuries and disorders, Myocardial Infarction

All genders

45+

Recruiting now

Department of Orthopaedic Surgery + Rehabilitation Medicine

Tufts Medical Center

Learn more

SOS

Orthopaedic Sports Medicine, Arthoscopy, and Related Surgery Registry Using the Web-Based Surgical Outcomes System

Orthopaedic surgery

All genders

12+

Recruiting now

Department of Orthopaedic Surgery + Rehabilitation Medicine

Tufts Medical Center

Learn more

The Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C)

Hepatology

All genders

18-70

Recruiting now

Department of Medicine, Division of Gastroenterology + Hepatology

Tufts Medical Center

Learn more

Voyage Study

VK2809 A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy, Safety, And Tolerability Of VK2809 Administered For 52 Weeks Followed By A 4-Week Off-Drug Phase In Subjects With Biopsy Proven Non-Alcoholic Steatohepatitis With Fibrosis

Non-alcoholic steato-hepatitis or fatty liver disease

All genders

18-75

Recruiting now

Department of Medicine, Division of Gastroenterology + Hepatology

Tufts Medical Center

Learn more

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase 2a, Open Label, Dose Escalation Study for Safety, Tolerability, and Efficacy of Hepatocyte Transplantation Into Periduodenal Lymph Nodes Among Subjects With End-Stage Liver Disease

Clinical Outcomes Of Primary Sclerosing Cholangitis In North America

Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer

HIP Fracture Accelerated surgical TreaTment And Care tracK 2 (HIP ATTACK-2) Trial

Orthopaedic Sports Medicine, Arthoscopy, and Related Surgery Registry Using the Web-Based Surgical Outcomes System

The Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C)

VK2809 A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy, Safety, And Tolerability Of VK2809 Administered For 52 Weeks Followed By A 4-Week Off-Drug Phase In Subjects With Biopsy Proven Non-Alcoholic Steatohepatitis With Fibrosis